Comparative analysis of TACE alone or plus RFA in the treatment of 167 cases of intermediate and advanced staged primary hepatocellular carcinoma

National Medical Journal of China

Volumn 90, Issue 41, 2010, Pages 2916-2921

  Zhao, Ming ^a   Wang, Jian Peng ^a   Wu, Pei Hong ^a   Zhang, Fu Jun ^a   Huang, Zi Lin ^a   Li, Wang ^a   Zhang, Liang ^a   Pan, Chang Chuan ^a   Li, Chuan Xing ^a   Jiang, Yong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Carcinoma, hepatocellular; Catheter ablation; Drug therapy, combination

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; POST TREATMENT SURVIVAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; ADULT; AGED; ARTIFICIAL EMBOLISM; CANCER STAGING; CATHETER ABLATION; COMPARATIVE STUDY; FEMALE; KAPLAN MEIER METHOD; LIVER TUMOR; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84871406892     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.41.009     Document Type: Article

References (16)

1. Poon R T, Ngan H, Lo C M, et al. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol, 2000, 73:109-114.
2. Marelli L, Shusang V, Buscombe J R, et al. Transarterial injection of (131) I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer. J Nucl Med, 2009, 50:871-877.
3. Kim K M, Kim J H, Park I S, et al. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. J Gastroenterol Hepatol, 2009, 24:806-814.
4. Yuen M F, Chan A O, Wong B C, et al. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients. Am J Gastroenterol, 2003, 98:1181-1185.
5. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer, 2005, 103:1201-1209.
6. 2003, 37:870-871.
7. 2000:457-458.
8. Eisenhauer E A, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 2009, 45:228-247.
9. 2005, 85:80-83.
10. Buscarini L, Buscarini E, Di Stasi M, et al. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med, 1999, 20:47-53.
11. Bowles B J, Machi J, Limm W M, et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg, 2001, 136:864-869.
12. Bruix J, Sala M, Llovet J M. Chemoembolization for hepatocellular carcinoma. Gastroenterology, 2004, 127: S179-188.
13. Liao C S, Yang K C, Yen M F, et al. Prognosis of small hepatocellular carcinoma treated by percutaneous ethanol injection and transcatheter arterial chemoembolization. J Clin Epidemiol, 2002, 55:1095-1104.
14. Veltri A, Moretto P, Doriguzzi A, et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (hepatocellular carcinoma). Eur Radiol, 2006, 16:661-669.
15. Yamakado K, Nakatsuka A, Akeboshi M, et al. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: short-term recurrences and survival. Oncol Rep, 2004, 11: 105-109.
16. 2007, 15:489-492.